112398-08-0

Applied Filters:

Keyword:'112398-08-0'

Showing 1-10 of 332 results for "112398-08-0" within Site Content

NHC-based Palladium Catalysts

In collaboration with Umicore AG and Co.,1 we are pleased to offer a series of robust Pd(II) and Pd(0) complexes employed as the linchpin in C–C bond forming reactions.

Louie Group – Professor Product Portal

Professor Louie's research focuses on the discovery and mechanistic understanding of new reactions catalyzed by transition metal complexes. She has developed a highly active Ni(0) catalyst that effectively mediates a variety of cycloaddition and isomerization reactions.

Echavarren Group – Professor Product Portal

The research of the Echavarren group centers on the development of new reactions based on the use of electrophilic complexes of Au(I), Pt(II), and other transition metals as catalysts and their applications in organic synthesis of complex, biologically active molecules. The

Please contact your local representative for additional help with your order, our products, and product selection.

Alkaline Phosphatase

We offer a broad range of alkaline phosphatase enzymes and substrates that are optimized for conjugation to antibodies and other proteins for your specific application needs.

Flavors and Fragrances New Product Offerings

As a leading global supplier of new flavor and fragrance ingredients, we are dedicated to providing you with high-quality aroma chemicals comprising of certified food grade, IFRA, natural, kosher, and halal ingredients.

Spermine Tetrahydrochloride for Molecular Biology

This product is suitable for DNA precipitation from low salt aqueous buffers. It has been tested for the absence of proteases and nucleases.

mRNA Health Conference

Join us at the 2022 mRNA Health Conference! Solutions for mRNA and Manufacturing and Formulation. Connect with our team and be sure to attend our technical presentations and poster sessions.

Differentiation of Primary Human Osteoblasts

Cell culture protocol used to differentiate primary human osteoblasts into bone cells in 2-3 weeks.

RNA Therapeutics & Delivery USA

Visit us at booth #7 to learn about our solutions to help you overcome your mRNA manufacturing and LNP formulation challenges.

Page 1 of 34